Company performance
Add to research
Current Price
as of Jul 11, 2025$44.48
P/E Ratio
N/A
Market Cap
$3.12B
Description
Add to research
Kymera Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of small molecule therapeutics that degrade disease-causing proteins. The company was founded by Bruce Lee Booth and Nello Mainolfi in September 2015 and is headquartered in Watertown, MA.
Metrics
Add to research
Overview
- HQWatertown, MA
- SectorHealth Technology
- IndustryBiotechnology
- TickerKYMR
- Price$44.48-1.61%
Trading Information
- Market cap$3.12B
- Float81.63%
- Average Daily Volume (1m)883,385
- Average Daily Volume (3m)893,324
- EPS-$3.10
Company
- Revenue$58.89M
- Rev growth (1yr)114.83%
- Net income-$65.58M
- Gross margin90.73%
- EBITDA margin-327.50%
- EBITDA-$72.38M
- EV$1.82B
- EV/Revenue30.85
- P/EN/A
- P/S60.54
- P/B3.68
- Debt/Equity10.98
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account